References
- Buyon JP, Wallace DJ. The endocrine system, use of exogenous estrogens, and the urogenital tract. In: Wallace DJ, Hahn BH eds. Dubois' lupus erythematosus, 5th edn. William & Wilkins 1997:817–34.
- Font J, Pallares L, Cervera R, Lopez-Soto A, Navarro M, Bosch X, Ingelmo M. Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis 1991;56:702–5.
- Ho CTK, Mok CC, Lau CS, Wong RWS. Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis 1998;57:437–40.
- Yoshida S, Castles JJ, Gershwin ME. The pathogenesis of autoimmunity in New Zealand mice. Semin Arthritis Rheum 1990;19:224–42.
- Carlsten H, Tarkowski A. Histocompatibility complex gene products and exposure to estrogen: two independent disease accelerating factors in murine lupus. Scand J Immunol 1993;38:341–7.
- Duvic M, Steinberg AD, Klassen LW. Effect of the anti-estrogen, nafoxidine, on NZB/W autoimmune disease. Arthri-tis Rheum 1978;21:414–7.
- Roubinian JR, Talal N, Greenspan JS, Goodman JR, Siiteri PK. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies and glomerulonephritis in NZB X NZW Fl mice. J Exp Med 1978;147:1568–83.
- Carlsten H, Tarkowski A, Holmdahl R, Nilsson LA. Estrogen is a potent disease accelerator in SLE-prone MRL-lpr/lpr mice. Clin Exp Immunol 1990;80:467–73.
- Carlsten H, Nilsson N, Johnson R, Backman K, Holmdahl R, Tarkowski A. Estrogen accelerates immune complex glomer-ulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL-lpr/lpr mice. Cell Immunol 1992;144:190 — 202.
- Sthoeger ZM, Chiorazzi N, Lahita RG. Regulation of immune response by sex hormones. I. In vitro effects of estradiol and testosterone on pokeweed mitogen-induced human B cell differentiation. J Immunol 1988;141:91–8.
- Kanda N, Tamaki K. Estrogen enhances immunoglobulin production by human peripheral blood mononuclear cells. J Allergy Clin Immunol 1999;103(2Pt1):282— 8.
- Kanda N, Tsuchida T, Tamaki K. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1999;42:328–37.
- Evans MJ, MacLaughlin S, Marvin RD, Abdou NI. Estrogen decreases in vitro apoptosis of peripheral blood mono-nuclear cells from women with normal menstrual cycles and decreases TNF-alpha production in SLE but not in normal cultures. Clin Immunol Immunopathol 1997; 82:258— 62.
- Grossman CJ. Regulation of the immune system by sex steroids. Endocr Rev 1984;5:435–55.
- Rose E, Pillsbury DM. Lupus erythematosus (erythema-todes) and ovarian function: observations on a possible relationship, with report of six cases. Ann Intern Med 1944;21:1022–34.
- Mok CC, Wong RWS, Lau CS. Ovarian failure and flares of systemic lupus erythematosus. Arthritis Rheum 1999;42: 1274 — 80.
- Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271 — 7.
- Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Bombardier C, Isenberg D, et al. Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: inter-national validation. J Rheumatol 1994;21:1468–71.
- Nossent JC, Bronsveld W, Swaak AJ. Systemic lupus erythematosus. III. Observations on clinical renal involve-ment and follow up of renal function: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 1989;48: 810–6.